Skip to content

Oliceridine versus Sufentanil in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Gynecologic Laparoscopic Surgery: A Randomized Controlled Trial

Oliceridine versus Sufentanil in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Gynecologic Laparoscopic Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110250
Enrollment
Unknown
Registered
2025-10-11
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Gynecologic Laparoscopic Surgery

Interventions

Experimental group (The Oliceridine Group):The experimental group received 3 mg of oliceridine for anesthetic induction.
Control group (The Sufentanil Group):The control group received 0.4 µg/kg of sufentanil for anesthetic induction.

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age < 80 years; 2.Scheduled for gynecologic laparoscopic surgery; 3. American Society of Anesthesiologists (ASA) physical status class I-III.

Exclusion criteria

Exclusion criteria: 1.Dyspnea or tracheal compression; 2.Obstructive sleep apnea syndrome (OSAS); 3. History of neurological disorders such as stroke or epilepsy; 4. Severe impairment of hepatic or renal function, heart failure, malignant tumors, etc.; 5.Long-term use of analgesic medications; 6.Mental disorders that would prevent cooperation with the study; 7.Known allergy to any drug used in this study; 8. Pregnancy, lactation, or intended pregnancy; 9.Current participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative nausea and vomiting (PONV) within 48 hours after surgery.;

Secondary

MeasureTime frame
The severity of PONV;The number of rescue antiemetics required;Postoperative patient satisfaction score;Time of tracheal extubation;PACU duration and postoperative hospital stay;Frequency of rescue pain medication;Hemodynamic event;

Countries

China

Contacts

Public ContactLiu Feng

Shanghai East Hospital

liufeng0295@163.com+86 188 5426 0295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026